Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, Bernabini G, Daini R, Casani A, Angelini D, Parrini M, Rossi A, Petrone I, Barsotti G, Donadio C, Donati G, Grazi G, Manca Rizza G, Garosi G, Sansoni E, Braccagni B, Sidoti A, Boracelli D, Biagioli M, Moriconi L, Finato V, Mannarino A, Grimaldi C, Pansa F, Imperiali P, Mura C, Bianchi S, Bigazzi R. Panichi V, et al. Among authors: rosati a. Blood Purif. 2011;32(1):7-14. doi: 10.1159/000321369. Epub 2011 Jan 14. Blood Purif. 2011. PMID: 21242686 Clinical Trial.
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G, Panichi V, Paoletti S, Grassi D, Bigazzi R, Beati S, Bernabini G, Rosati A, Ferri C, Taddei S, Ghiadoni L; RISCAVID investigators. Desideri G, et al. Among authors: rosati a. Nephrol Dial Transplant. 2011 Sep;26(9):2983-8. doi: 10.1093/ndt/gfq823. Epub 2011 Feb 8. Nephrol Dial Transplant. 2011. PMID: 21303961
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
Panichi V, Rosati A, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, Bernabini G, Grazi G, Rizza GM, Migliori M, Giusti R, Lippi A, Casani A, Barsotti G, Tetta C; RISCAVID Study Group. Panichi V, et al. Among authors: rosati a. Nephrol Dial Transplant. 2011 Aug;26(8):2641-8. doi: 10.1093/ndt/gfq802. Epub 2011 Feb 16. Nephrol Dial Transplant. 2011. PMID: 21325348
Divert to ULTRA: differences in infused volumes and clearance in two on-line hemodiafiltration treatments.
Panichi V, De Ferrari G, Saffioti S, Sidoti A, Biagioli M, Bianchi S, Imperiali P, Gabbrielli C, Conti P, Patrone P, Falqui V, Rombolà G, Mura C, Icardi A, Mulas D, Rosati A, Santori F, Mannarino A, Tomei V, Bertucci A, Steckiph D, Palla R. Panichi V, et al. Among authors: rosati a. Int J Artif Organs. 2012 Jun;35(6):435-43. doi: 10.5301/ijao.5000106. Int J Artif Organs. 2012. PMID: 22669588 Clinical Trial.
High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
Panichi V, Scatena A, Rosati A, Giusti R, Ferro G, Malagnino E, Capitanini A, Piluso A, Conti P, Bernabini G, Migliori M, Caiani D, Tetta C, Casani A, Betti G, Pizzarelli F. Panichi V, et al. Among authors: rosati a. Nephrol Dial Transplant. 2015 Apr;30(4):682-9. doi: 10.1093/ndt/gfu345. Epub 2014 Nov 10. Nephrol Dial Transplant. 2015. PMID: 25385719 Clinical Trial.
444 results